4Granowitz EV, Brown RB, Macrolides in community-acquired pneumonia:does the bell toll for thee? [ J ]. Chest,2005,128 : 1089 - 1093.
5Chen DK, McGeer A, de Azavedo JC, et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada[ J]. N Engl J Med,1999,341:233 -239.
6Neuhauser MM,Weinstein RA, Rydman R,et al. Antibiotic resistance among Gram-negative bacilli in US Intensive Care Units[ J]. JAMA ,2003,289:885 - 888.
7Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe baeteremie pneumococcal pneumonia [ J ]. Arch Intern Med ,2001,161 ( 15 ) : 1837 - 1842.
8Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia[J]. Am J Respir Crit Care Med,2004,170: 440-444.
9Plouffe JF, Breiman RF, Fields BS, et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization [ J ]. Clin Infect Dis ,2003,37 : 1475 - 1480.
8Hincapie JP, Castrillon CA, Yepes FL, et al, Microbiological effects of periodontal therapy plus azithromycin in patients with diabetes: results from a randomized clinical trial [ J ]. Acta Odontol Latinoam, 2014,27( 2): 89-95.
9Zarogoulidis P, Papanas N, Kinumis I, et al. Macrolides : from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases[ J]. Eur J Clin Pharmacol,2012, 68 ( 5 ) :479-503.
10Toledo Junior A, Daher AB, Amaral TA, et al. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase l~ clinical trial in Brazil [ J ]. Rev Soc Bras Med Trop,2014,47 ( 6 ) :756-762.
